Teduglutide study for children with short bowel syndrome
Part of Digestive system clinical trials.
This trial tests the medicine teduglutide in children (ages 1–17) with Short Bowel Syndrome who need IV nutrition. The goal is to see if teduglutide can help them reduce or stop IV nutrition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 and 17 years old.
- They must have a diagnosis of Short Bowel Syndrome (SBS).
- Their IV nutrition (PN) must have been stable with very little change for the past 3 months.
- They must not have had a bowel lengthening surgery in the last 3 months.
- They must weigh at least 10 kg (about 22 pounds).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at short bowel syndrome in children who have had intestinal surgery. It may help doctors understand how to better treat this condition.
This study tests a new medicine called apraglutide, given as a shot, to see if it can help adults with short bowel syndrome and intestinal failure reduce their need for intravenous nutrition (parenteral support). The study compares apraglutide to a placebo (a shot with no medicine) to check if it is safe and effective.
This study looks at how bacteria in your gut help your digestive system adapt after short bowel surgery. Researchers will track your microbiota (the trillions of bacteria in your gut) to understand how it changes and helps your body adjust to having less small intestine.
This study tests a medicine called teduglutide for adults in China with short bowel syndrome who need long-term IV nutrition or fluids (parenteral support). The goal is to see if teduglutide can help them reduce or stop the need for these IV treatments.
This trial tests a new medication called glepaglutide to see if it can help people with short bowel syndrome (SBS) who need IV nutrition or fluids at least 3 days a week. The goal is to reduce or even stop the need for these IV treatments.
This trial tests a new medicine called PJ009 for people with short bowel syndrome who need intravenous (IV) nutrition support. It aims to help reduce the need for IV nutrition. To join, you must have been dependent on IV nutrition for at least six months and be on a stable schedule.
Hear when a new Short Bowel Syndrome (SBS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.